Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-05T07:58:28.572Z Has data issue: false hasContentIssue false
  • English
  • Français

Reader' Forum

Published online by Cambridge University Press:  02 January 2015

Patti J. Miller
Patti J. Miller*
Affiliation:
University of Virginia, Medical Center Virginia Statewide, Infection Control Program, Charlottesville, Virginia 22908
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments
Information
Infection Control & Hospital Epidemiology , Volume 3 , Issue 1 , February 1982 , pp. 76 - 77
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1982

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Merck, Sharp and Dohme, . Hepatitis B: Its prevention by vaccine. J Infect Dis 1981; 143(2):301–304.Google Scholar
2.Krugman, S. Giles, JP, Hammond, J. Hepatitis virus: Effect of heal on the infectivity and antigenicity of the MS-1 and MS-2 strains. J Infect Dis 1970; 122:432–436.Google Scholar
3.Krugman, S, Giles, JP, Hammond, J. Viral hepatitis, type B (MS-2 strain): Studies on active immunization. JAMA 1971; 217:41–45.CrossRefGoogle ScholarPubMed
4.Purcell, RH, Gerin, JL. Hepaiitis B vaccines: A status report. In: Viral Hepatitis. Vyas, GN, Cohen, SN, Schmid, R, eds. Philadelphia: Franklin Inst Pr, 1978, pp 491–505.Google Scholar
5.Hilleman, MR, et al. Clinical and laboratory sludies of HBsAg vaccine. In: Viral Hepatitis. Vyas, GN, Cohen, SN, Schmid, R, eds. Philadelphia: Franklin Inst Pr, 1978, pp 525–537.Google Scholar
6.Maupas, P, et al. Immunization against hepatitis B in man: A pilot study of two years duration. In: Viral Hepatitis. >Vyas, GN, Cohen, SN, Schmid, R, eds. Philadelphia: Franklin Inst Pr, 1978, pp 539–556.Google Scholar
7.Tao, CM, et al. A preliminary study on hepatitis B vaccine. Chin Med J (Engl.) 1978; 4:101–110.Google Scholar
8.Reesink, HW, et al. The preparation and evaluation of a hepatitis-B vaccine in the Netherlands. In: Viral Hepatitis. Vyas, GN, Cohen, SN, Schmid, R, eds. Philadelphia: Franklin Inst Pr, 1978, p 714.Google Scholar
9.Hollinger, FB, et al. Experimental hepatitis B polypeptide vaccine in chimpanzees. In: Viral Hepatitis. Vyas, GN, Cohen, SN, Schmid, R, eds. Philadelphia: Franklin Inst Pr, 1978, pp 557–567.Google Scholar
10.Skelly, J, Howard, CR, Zuckerman, AJ. Analysis of hepatitis B surface antigen components solubilized with Triton-X-100. J Gen Virol 1979; 44:679–689.CrossRefGoogle ScholarPubMed
11.Szmuness, W, et al. Hepatitis B vaccine: Demonstraiion of efficacy in a controlled clinical trial in a high-risk population in the United Slates. N Engl J Med 1980; 303(15):833–841.Google Scholar
12.Barin, F. et al. Large scale purification of hepaiitis B surface antigen (HBsAg). Ann Microbiol (Inst Pasteur) 1978; 129B:87–100.Google ScholarPubMed
13.Maupas, P, et al. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children: Controlled trial in an endemic area (Senegal). Lancet 1981; 1:289–292.CrossRefGoogle Scholar
14.Stevens, CE, et al. Hepatitis B vaccine: Immune responses in haemodialysis patients. Lancet 1980; 2:1211–1213.Google Scholar
15.Crosnier, J, et al. Randomized placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, medical staff. Lancet 1981; 1:455–459.CrossRefGoogle ScholarPubMed
16.Szmuness, W, et al. Passive-active immunization against hepatitis B: Immunogenicity studies in adult Americans. Lancet 1981; 2:575–577.Google Scholar